glp-1 approved for weight loss The New Management Meds GLP-1s in the “Barbecue Belt
Description
Q: Will my appetite return immediately if I stop
Importantly, these medications carry a boxed warning and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
The medication, which is administered once a month as a subcutaneous shot is approved by many countries, including the United States and Europe
Introduction Despite major advance in treatment, cardiovascular diseases are still one of the leading causes of mortality and morbidity in the world
As such, GLP-1RAs have become the most widely prescribed anti-obesity agents worldwide [8, 9]
